No Data
A share investment lightning rod on December 10: Shareholders Yinkun Company and Longxin Construction plan to reduce their total holdings by no more than 2%
PHARMARON's major shareholder, Xin Zhongkang, and its concerted actors completed the Shareholding reduction of 16 million Stocks; two shareholders of Zhi Xin Precision plan to collectively reduce no more than 3.0375% of their Shares; Shenzhen SDG Service shareholders, Yinkun Company and Longxin Construction, plan to collectively reduce no more than 2% of their Shares; Wuxi Zhenhua's shareholder Wuxi Jinfengyu plans to reduce 3% of its Shares; Hainan Poly Pharm is currently under investigation by the Securities Regulatory Commission, and the Stocks face the risk of being subjected to significant illegal delisting; Zhejiang Yiming Food's Stocks have been suspended for 10 consecutive Trading days, facing the risk of a significant decline in the short term; Tibet Summit Resources received a warning letter from the Tibet Securities Regulatory Bureau.
Pharmaron (300759.SZ) major shareholder Xinzhi Kangkang's concerted action has completed a shareholding reduction of 16 million shares.
Pharmaron (300759.SZ) announced that the shareholder holding more than 5% of the shares, Shenzhen Xinzhongkangcheng Investment Partnership...
Bearish landing? Hong Kong stocks in the pharmaceutical sector collectively strengthen with wuxi apptec rising over 8%.
① How much impact did the biological safety legislation have on domestic pharmaceutical stocks previously? ② How do industry insiders view the subsequent development of the biological legislation?
The concept of contract research organizations started positively, wuxi bio (02269) rose by 13.03%, and the U.S. Biosafety Act was not included in the 2025 Fiscal Year Defense Authorization Act.
Jinwu Financial News | The contract research organizations concept started off positively, as of the time of publication, Wuxi Bio (02269) is up 13.03%, Wuxi AppTec (02359) is up 11.72%, Pharmaron (03759) is up 9.14%, Genscript Bio (01548) is up 4.98%, and Tigermed (03347) is up 4.87%. In terms of news, on December 7 local time in the USA, the final agreement text of the 2025 fiscal year National Defense Authorization Act (NDAA) released by the military committees of both the House and Senate did not include the biosafety act. Morgan Stanley stated, USA
Hong Kong stock concept tracking | The biocontrol bill was not included in the latest version of NDAA. Institutions are bullish on the bottom opportunities in the CXO sector (with concept stocks attached).
On December 7, 2024, local time in the USA, the US Congressional Armed Services Committees in both the House and the Senate released the final agreement text of the 2025 National Defense Authorization Act (NDAA), which incorporates proposals from both chambers.
Honkong stock market movement | CRO concept stocks collectively opened higher as the bioprotective legislation was not included in the final version of the NDAA by the U.S. Senate and House of Representatives.
CRO concept stocks opened higher collectively. As of the time of writing, wuxi bio (02269) increased by 13.03%, trading at 19.6 Hong Kong dollars; wuxi apptec (02359) rose by 11.72%, trading at 61 Hong Kong dollars; pharmaron (03759) climbed by 9.14%, trading at 16 Hong Kong dollars.
102884128 : getting disappointed with this counter. every day drop.